Escherichia coli

The genus name Escherichia honors the German-Austrian pediatrician Theodor Escherich (1857–1911), who first isolated and described this bacterium from the feces of healthy infants in 1885, in the laboratory of Otto von Bollinger in Munich. Escherich originally named the organism Bacterium coli commune (the common colon bacillus). In 1919, Aldo Castellani and Albert John Chalmers established the new genus Escherichia and reclassified the organism under its current binomial, Escherichia coli. The species epithet coli is the genitive of the Latin neuter noun colon (the large intestine), reflecting the bacterium's primary habitat (LPSN: co'li, L. gen. neut. n. coli, of the colon).

According to LPSN (List of Prokaryotic names with Standing in Nomenclature), E. coli is a validly published correct name and is explicitly recommended for medical use. Its NCBI Taxonomy ID is 562, and the taxonomic authority is recorded as (Migula 1895) Castellani and Chalmers 1919 (Approved Lists 1980). E. coli is the type species of the genus Escherichia, which in turn is the type genus of the family Enterobacteriaceae.

In a single sentence, E. coli can be summarized as a multifaceted bacterium that is simultaneously a human gut commensal, the most important model organism in the history of molecular biology, and—through certain pathogenic strains and antibiotic resistance—a global public health threat.

The full taxonomic placement of E. coli is as follows: Domain Bacteria, Phylum Pseudomonadota (formerly Proteobacteria), Class Gammaproteobacteria, Order Enterobacterales, Family Enterobacteriaceae, Genus Escherichia, Species E. coli. The type strain is ATCC 11775 (= DSM 30083 = NCTC 9001), and its complete genome was sequenced as part of the GEBA (Genomic Encyclopedia of Bacteria and Archaea) project (Meier-Kolthoff et al., 2014).

E. coli is a genetically and phenotypically extraordinarily diverse species. Pangenome analyses have identified over 30,000 gene families across the species, yet the core genome shared by virtually all strains comprises only about 2,000–3,000 genes—roughly 20% of a typical E. coli genome (Lukjancenko et al., 2010; Abram et al., 2021). A large-scale Mash-based phylogenomic study published in 2021 analyzed 10,667 E. coli genomes and identified up to 14 phylogroups, expanding on the traditionally recognized groups A, B1, B2, C, D, E, F, and G (Abram et al., 2021). Phylogroups B2 and D are predominantly associated with extraintestinal infections (urinary tract infections, sepsis), while A and B1 are mainly commensals.

DNA–DNA hybridization and whole-genome analyses have established that the four species of the genus Shigella (S. dysenteriae, S. flexneri, S. boydii, S. sonnei) fall genetically within E. coli (Brenner, 1984; LPSN). However, because of their medical importance as causative agents of bacillary dysentery and longstanding historical convention, they are maintained as a separate genus—a phenomenon referred to in taxonomy as "taxa in disguise." Furthermore, a 2023 study reported that some genomes classified as E. coli in NCBI may represent reproductively isolated, distinct species, and the debate over species boundaries within E. coli continues (Gonzalez-Alba et al., 2023).

Below the species level, E. coli is extensively classified by serotyping based on three major surface antigens. O antigens (somatic antigens, components of the lipopolysaccharide layer) encompass approximately 190 known serogroups. H antigens are based on the flagellar protein flagellin (approximately 53 types), and K antigens are based on capsular polysaccharides (approximately 80 types). For example, O157:H7 denotes a serotype possessing O antigen type 157 and H antigen type 7, one of the most widely recognized pathogenic serotypes.

E. coli is a straight, rod-shaped (bacillus) bacterium with rounded ends. Cell dimensions vary with growth conditions but typically measure approximately 1.0–3.0 μm in length (commonly about 2.0 μm), 0.25–1.0 μm in width (commonly about 0.5 μm), with a cell volume of approximately 0.6–0.7 μm³ (about 1 fL) (BioNumbers). Cells exist singly or in pairs, and under nutrient depletion or stress conditions, morphology can range from coccoid to elongated filamentous forms.

E. coli possesses the characteristic double-membrane cell envelope of Gram-negative bacteria. The inner membrane (cytoplasmic membrane) is a phospholipid bilayer involved in nutrient transport and energy production (electron transport chain). The peptidoglycan layer (murein layer) is relatively thin at approximately 2–7 nm—much thinner than in Gram-positive bacteria—and serves as the structural scaffold maintaining cell shape. The outer membrane is the most distinctive feature of the E. coli cell wall; its inner leaflet consists of phospholipids, while the outer leaflet contains lipopolysaccharide (LPS). LPS is composed of three regions: lipid A (endotoxin activity), core oligosaccharide, and O-antigen polysaccharide. In Gram-negative sepsis, LPS is the primary molecule responsible for endotoxic shock. The outer membrane contains porins (e.g., OmpF, OmpC)—water-filled protein channels that allow selective passage of small hydrophilic molecules.

E. coli has a peritrichous flagellar arrangement, with approximately 5–10 flagella distributed over the entire cell surface. Flagella are composed of flagellin protein and rotate by proton motive force, enabling swimming at speeds of approximately 25 μm per second (roughly 10 body lengths per second) in liquid environments. However, not all strains are motile; some pathogenic strains (e.g., EIEC) are non-motile. Pili (fimbriae) are short, thin proteinaceous appendages crucial for adhesion to host cell surfaces. Type 1 fimbriae carry the FimH adhesin, which binds mannose residues, while P pili (pap pili) are critical for UPEC adhesion to P-blood group antigens on urinary epithelial cells. E. coli does not form spores.

When subjected to Gram staining, E. coli stains pink to red with the counterstain safranin, because the thin peptidoglycan layer fails to retain the crystal violet–iodine complex during ethanol decolorization.

The E. coli genome consists of a single circular double-stranded DNA chromosome. The complete genome of the best-known laboratory reference strain, K-12 MG1655, was sequenced and published by Blattner et al. in 1997 and deposited in GenBank (accession U00096, subsequently updated to U00096.3). The genome size is 4,641,652 bp (approximately 4.6 Mb), with a GC content of 50.8% and approximately 4,300 protein-coding genes. However, genome sizes of naturally isolated E. coli strains range considerably, from approximately 3.98 Mb (the minimized K-12 derivative MDS42) to 5.86 Mb (pathogenic strain O26:H11 11368).

The E. coli pangenome is highly open, with over 30,000 identified gene families across the species. Only approximately 2,000–3,000 core genes are conserved in virtually all strains; the remainder constitutes the accessory genome, largely acquired through horizontal gene transfer (HGT) via conjugation, transduction, and transformation. An estimated 18% of the K-12 MG1655 genome was horizontally acquired since the divergence from Salmonella (Lawrence and Ochman, 1998). Many virulence genes (toxins, adhesins, iron acquisition systems) are carried on pathogenicity islands, plasmids, or lysogenic phages—the transfer of Shiga toxin genes to E. coli O157:H7 via transduction being a prime example. According to EcoCyc, approximately 38% of genes in the K-12 genome remain functionally uncharacterized, and elucidating their roles is an active area of research.

DNA replication initiates at a single origin of replication (oriC) and proceeds bidirectionally. The C period (time to replicate the entire chromosome) is approximately 40 minutes. Under rapid growth conditions, the generation time (approximately 20 minutes) can be shorter than the C period, made possible by overlapping replication: new rounds of replication initiate before the previous round is completed, so that multiple replication forks coexist simultaneously within a single cell.

The vast majority of E. coli strains (over 90%) are harmless commensals, but strains that have acquired specific virulence factors cause a wide spectrum of infectious diseases. Diarrheagenic E. coli (DEC) strains are classified into six major pathotypes (Nataro and Kaper, 1998; Kaper et al., 2004).

Enterohemorrhagic E. coli (EHEC/STEC) produce Shiga toxins (Stx1 and/or Stx2), causing hemorrhagic colitis and hemolytic uremic syndrome (HUS). HUS is characterized by acute renal failure, microangiopathic hemolytic anemia, and thrombocytopenia, and can be fatal, particularly in children under five and the elderly. The best-known serotype, O157:H7, was first recognized in 1982 during outbreaks of bloody diarrhea traced to contaminated hamburgers in Oregon and Michigan, USA. Enterotoxigenic E. coli (ETEC) produce heat-labile (LT) and heat-stable (ST) enterotoxins and are a leading cause of traveler's diarrhea in developing countries. Enteropathogenic E. coli (EPEC) use the adhesin intimin to form attaching and effacing (A/E) lesions and primarily cause watery diarrhea in infants. Enteroinvasive E. coli (EIEC), like Shigella, invade intestinal mucosal epithelial cells, producing dysentery-like illness. Enteroaggregative E. coli (EAEC) is associated with persistent diarrhea, and diffusely adherent E. coli (DAEC) is linked primarily to childhood diarrhea.

Regarding extraintestinal infections, uropathogenic E. coli (UPEC) is the most common causative agent of urinary tract infections (UTIs), accounting for approximately 80–90% of community-acquired UTI cases (Foxman, 2014). UPEC employs virulence factors including type 1 fimbriae (FimH), P pili, alpha-hemolysin (HlyA), and aerobactin to adhere to and invade urinary epithelial cells. Neonatal meningitis-associated E. coli (NMEC) carrying the K1 capsular antigen is a leading cause of neonatal bacterial meningitis. E. coli is also a major agent in healthcare-associated infections, including bloodstream infections, catheter-associated UTIs, intra-abdominal infections, and ventilator-associated pneumonia.

Diagnosis relies on culture (characteristic colony morphology on MacConkey or EMB agar), biochemical testing (lactose fermentation positive, indole positive, citrate utilization negative, etc.), serotyping, and PCR-based detection of virulence genes.

E. coli is distributed worldwide and is found in the intestines of over 90% of healthy humans. Pathogenic E. coli is transmitted primarily via the fecal-oral route, through contaminated food (undercooked beef, leafy greens, unpasteurized milk or juice), contaminated drinking water, direct contact with infected individuals, and contact with animals—particularly ruminants, the primary reservoir for STEC.

Notable large-scale STEC/EHEC outbreaks include the 1996 Sakai City, Japan outbreak (approximately 9,000 cases of O157:H7 linked to contaminated white radish sprouts), the 2006 US outbreak (O157:H7 traced to contaminated spinach), and the 2011 German outbreak (O104:H4 linked to fenugreek sprouts, resulting in 54 deaths and approximately 850 HUS cases). The 2011 German outbreak was caused by a hybrid pathotype combining EAEC and STEC characteristics, demonstrating the evolutionary dynamism of E. coli pathogenicity.

ETEC-associated diarrhea accounts for hundreds of millions of cases worldwide annually and is a major cause of mortality in children under five in developing countries. UTI caused by UPEC is one of the most common bacterial infections globally, with an estimated 50–60% of women experiencing at least one episode in their lifetime.

The immune response to E. coli infection involves both innate and adaptive immunity. Secretory IgA at the intestinal mucosa serves as a first line of defense, LPS activates a potent innate immune response via TLR4 (Toll-like receptor 4), and flagellin is recognized by TLR5. However, pathogenic strains possess various immune evasion mechanisms, including complement inhibition by capsular polysaccharides and host cell signaling manipulation via type III secretion systems.

Antibiotic use in STEC/EHEC infections is controversial. Because antibiotics may promote Shiga toxin release and increase the risk of HUS, antibiotic therapy is generally not recommended for STEC infections; supportive care (fluid replacement, electrolyte correction) is the standard approach. For UTIs caused by UPEC, trimethoprim-sulfamethoxazole, nitrofurantoin, fosfomycin, and fluoroquinolones are commonly used, but rising resistance rates are making empirical antibiotic selection increasingly difficult.

Antibiotic resistance is among the most serious public health issues associated with E. coli. ESBL-producing E. coli are resistant to most beta-lactam antibiotics, including third-generation cephalosporins. Carbapenem-resistant Enterobacterales (CRE) are resistant even to carbapenems—antibiotics of last resort. The plasmid-mediated colistin resistance gene mcr-1, first reported in China in 2015, confers transferable resistance to colistin, the last-line antimicrobial. According to the CDC's 2019 Antibiotic Resistance Threats Report, over 2.8 million antibiotic-resistant infections occur annually in the United States, causing more than 35,000 deaths, with ESBL-producing Enterobacterales classified as a serious threat. The 2024 WHO BPPL designated both carbapenem-resistant and third-generation cephalosporin-resistant Enterobacterales as critical-priority pathogens.

Emerging therapeutic approaches include bacteriophage therapy. In the largest phage therapy clinical trial to date (2024), a six-strain phage cocktail by Locus Biosciences demonstrated in vitro efficacy against 94% of clinical E. coli isolates (C&EN, 2024). Additionally, engineered phages carrying CRISPR-Cas systems have been shown to selectively eliminate target bacteria within E. coli biofilms (Kiga et al., 2023). Prevention strategies include thorough handwashing, complete cooking of meats (ground beef to an internal temperature of at least 71°C / 160°F), avoiding unpasteurized dairy products, adequate washing of fruits and vegetables, preventing cross-contamination during food preparation, and avoiding contaminated water.

The primary habitat of E. coli is the lower intestinal tract (large intestine) of warm-blooded animals, including humans. Although facultative anaerobes including E. coli constitute only about 0.1% of the total gut microbiota, E. coli is found in over 90% of healthy adults, and an average of approximately five distinct E. coli strains coexist in the healthy human gut (Tenaillon et al., 2010). Within the intestine, E. coli produces vitamin K2 (menaquinone) and vitamin B12 for the host (Bentley and Meganathan, 1982), provides colonization resistance against pathogenic bacteria, and consumes oxygen to create favorable conditions for obligate anaerobes. The E. coli Nissle 1917 strain has been commercialized as a probiotic pharmaceutical (Mutaflor) for the prevention of intestinal infections.

Metabolically, E. coli is a chemoheterotroph that performs aerobic respiration in the presence of oxygen and mixed acid fermentation or anaerobic respiration in its absence. Mixed acid fermentation products include lactate, succinate, ethanol, acetate, and formate (which is further cleaved to CO₂ and H₂). Hydrogen gas production is important for interspecies hydrogen transfer with methanogenic archaea and sulfate-reducing bacteria in the gut. The phenomenon of catabolite repression—preferential glucose consumption over lactose when both are available—became the classical model of gene regulation through Jacob and Monod's research on the lac operon.

Outside the host, E. coli can survive for limited periods in the environment and is therefore widely used as an indicator organism for fecal contamination in water quality and food safety monitoring. Recent research has identified environmentally persistent E. coli lineages capable of prolonged survival and even growth in soil and freshwater, necessitating caution in interpreting the presence of E. coli solely as evidence of recent fecal contamination.

The scientific history of E. coli begins in 1885, when Theodor Escherich first isolated and described this bacterium from the feces of healthy infants at the laboratory of Otto von Bollinger in Munich, Germany (Escherich, 1885). Escherich used the novel staining technique developed by Hans Christian Gram to characterize the organism. In 1922, a strain isolated from the stool of a convalescent diphtheria patient was deposited in the Stanford University strain collection as K-12, and this strain would later become the central experimental tool of molecular biology.

In 1946, Joshua Lederberg and Edward Tatum used the K-12 strain to discover bacterial genetic recombination (conjugation), a landmark event that inaugurated the field of bacterial genetics (Lederberg and Tatum, 1946) and led to the 1958 Nobel Prize in Physiology or Medicine. Subsequently, E. coli was instrumental in the deciphering of the genetic code (1968 Nobel Prize), the discovery of gene regulation mechanisms (the operon concept; 1965 Nobel Prize), the discovery of restriction enzymes (1978 Nobel Prize), recombinant DNA technology (1980 Nobel Prize), ATP synthesis mechanisms (1997 Nobel Prize), protein signal sequences (1999 Nobel Prize), and green fluorescent protein (GFP; 2008 Nobel Prize)—a total of 11 Nobel Prize-winning discoveries (NCBI Bookshelf, NBK562895).

Biotechnology milestones include the first recombinant DNA experiment by Cohen and Boyer in 1973, Genentech's production of recombinant human insulin in E. coli in 1978, and the FDA approval of Humulin on October 28, 1982—the first recombinant pharmaceutical ever approved (FDA, 2022). Today, E. coli remains the most widely used host organism for recombinant protein production, employed in the manufacture of insulin, growth hormone, interferon, and industrial enzymes.

The E. coli Long-Term Evolution Experiment (LTEE), initiated by Richard Lenski in 1988, tracks the evolution of 12 independent populations descended from a single ancestral strain in real time—the world's longest-running evolution experiment. The populations surpassed 80,000 generations in August 2024 in Jeffrey Barrick's laboratory at UT Austin, continued to 82,000 generations, and in September 2025 returned to Michigan State University, where the experiment continues (the-ltee.org, 2025). The evolution of aerobic citrate utilization in one population at approximately generation 31,500 is regarded as a landmark case of observed microbial speciation in the laboratory.

Salmonella enterica diverged from E. coli approximately 102 million years ago from a common ancestor. The two genera share high genomic synteny, but Salmonella is distinguished by its inability to ferment lactose, its production of H₂S, and its intracellular parasitism. Shigella, as noted above, is genetically within E. coli but is maintained as a separate genus for medical convention, distinguished by its non-motility, inability to ferment lactose, and capacity for intracellular invasion.